TY  - JOUR
T1  - DIetary supplements
AU  - Mitka M
Y1  - 2009/04/08
N1  - 10.1001/jama.2009.447
JO  - JAMA
SP  - 1427
EP  - 1427
VL  - 301
IS  - 14
N2  - 
The March 5 report called for additional FDA regulatory authority over dietary supplement manufacturing facilities and expanded reporting of adverse health effects of these products. The report also recommended that the FDA issue guidance to industry to clarify which supplement ingredients require safety documentation before they can be marketed and also that the agency take steps to improve consumer understanding about these products (http://energycommerce.house.gov/Press_111/20090302/gaoreport.pdf).

SN  - 0098-7484
M3  - doi: 10.1001/jama.2009.447
UR  - http://dx.doi.org/10.1001/jama.2009.447
ER  -